Heli Harvala profiilikuva
Heli
Harvala
professori, biolääketieteen laitos
MD, PhD, EUPHEM Alumni, FRCPath

Ota yhteyttä

Julkaisut

Järjestä:

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial (2022)

Intensive Care Medicine
Fish M, Rynne J, Jennings A, Lam C, Lamikanra AA, Ratcliff J, Cellone-Trevelin S, Timms E, Jiriha J, Tosi I, Pramanik R, Simmonds P, Seth S, Williams J, Gordon AC, Knight J, Smith DJ, Whalley J, Harrison D, Rowan K, Harvala H, Klenerman P, Estcourt L, Menon DK, Roberts D, Shankar-Hari M, REMAP-CAP Immunoglobulin Domain UK Investigators

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response (2022)

Microbiology spectrum
Otter AD, Bown A, D'Arcangelo S, Bailey D, Semper A, Hewson J, Catton M, Perumal P, Sweed A, McKee DF, Jones J, Harvala H, Lamikanra A, Zambon M, Andrews N, Whitaker H, Linley E, Mentzer AJ, Skelly D, Knight JC, Klenerman P, UKHSA Porton Euroimmun testing group, Amirthalingam G, Taylor S, Rowe C, Vipond R, Brooks T